Jiejie Yang and colleagues found that EVA1A expression was notably downregulated in HCC tissues and HCC cells, and was correlated with poor clinical prognosis and the clinical stage of advanced TNM in patients with HCC. Here, EVA1A is linked to hepatocellular carcinoma.